Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
Advanced Science · 2025
DOI: 10.1002/advs.202408373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Dewen Zhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, 510130, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Caveolin 1, Killer Cells, Natural, Immunotherapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The cell membrane transport capacity and surface targets of multiple myeloma (MM) cells heavily influence chemotherapy and immunotherapy. Here, it is found that caveolin‐1 (CAV1), a primary component of membrane lipid rafts and caveolae, is highly expressed in MM cells and is associated with MM progression and drug resistance. CAV1 knockdown decreases MM cell adhesion to stromal cells and attenuates cell adhesion‐mediated drug resistance to bortezomib. CAV1 inhibition in MM cells enhances natural killer cell‐mediated cytotoxicity through increasing CXCL10, SLAMF7, and CD112. CAV1 suppression reduces mitochondrial membrane potential, increases reactive oxygen species, and inhibits autophagosome‐lysosome fusion, resulting in the disruption of redox homeostasis. Additionally, CAV1 knockdown enhances glutamine addiction by increasing ASCT2 and LAT1 and dysregulates glutathione metabolism. As a result of CAV1 inhibition, MM cells are more sensitive to starvation, glutamine depletion, and glutamine transporter inhibition, and grow more slowly in vivo in a mouse model treated with bortezomib. The observation that CAV1 inhibition modulated by 6‐mercaptopurine, daidzin, and statins enhances the efficacy of bortezomib in vitro and in vivo highlights the translational significance of these FDA‐approved drugs in improving MM outcomes. These data demonstrate that CAV1 serves as a potent therapeutic target for enhancing chemotherapy and immunotherapy for MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, 510130, China.
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, 511436, China.
- School of Nursing, Guangzhou Medical University, Guangzhou, 510182, China.
- School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, 511436, China.
- Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium.
ORCID-Profile: Jinheng Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Tertiary Education Scientific Research Project of Guangzhou Municipal Education Bureau
- Projects in Key Areas of General Universities in Guangdong Province
Zitieren
APA
Zhan, D., Du, Z., Zhang, S., Huang, J., Zhang, J., Zhang, H., Liu, Z., Menu, E., & Wang, J. (2025). Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202408373
Vancouver
Zhan D, Du Z, Zhang S, Huang J, Zhang J, Zhang H, et al. Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy. Advanced Science. 2025. doi:10.1002/advs.202408373
BibTeX
@article{Zhan2025,
author = {Zhan, Dewen and Du, Zhimin and Zhang, Shang and Huang, Juanru and Zhang, Jian and Zhang, Hui and Liu, Zhongrui and Menu, Eline and Wang, Jinheng},
title = {Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202408373}
}
EUVIMED